Skip to main content

Genotype–Phenotype of RPE65 Mutations: A Reference Guide for Gene Testing and Its Clinical Application

  • Chapter
  • First Online:
Advances in Vision Research, Volume III

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 447 Accesses

Abstract

The RPE65 gene encodes a retinal pigment epithelium-specific isomerase that catalyzes the conversion of all-trans retinyl esters to 11-cis retinol, the activity of which affects the formation of visual pigment in photoreceptors. Mutations in RPE65 in inherited retinal dystrophies have been studied widely worldwide, especially now that gene therapy for patients with RPE65 mutations is available in the clinic. The aim of this study is to reveal the RPE65 mutation spectrum and frequency, the associated phenotypic characteristics, and potential genotype–phenotype correlations. In total, 201 mutations in RPE65 were identified in 479 patients from 353 families based on data reported in the literature. Mutations in 349 families caused autosomal recessive retinal degeneration, while a c.1430A>G (p.Asp477Gly) mutation in four families resulted in autosomal dominant retinal degeneration resembling retinitis pigmentosa, choroideremia, or vitelliform macular dystrophy with incomplete penetrance. Mutations identified in families with biallelic RPE65 mutations included missense (113/200 [56.5%]), frameshift indel (39/200 [19.5%]), splicing defect (24/200 [12.0%]), nonsense (19/200 [9.5%]), inframe indel (4/200 [2.0%]), and start loss (1/200 [0.5%]). A significant reduction in visual acuity was noticeable at 15 years of age and at 35 years of age, suggesting a critical window for treatment including gene therapy. Two major types of fundus changes were observed: (1) mild or obvious tapetoretinal degeneration, generalized or located mainly in the mid-peripheral retina; and (2) fundus albipunctatus-like retinopathy. Typical bone-spicule pigmentation was rarely seen in early childhood but may be observed after 35 years of age. A severe phenotype (Leber congenital amaurosis) is frequently associated with biallelic loss-of-function mutations, while milder phenotypes are more likely to be associated with one or two missense mutations. The overall information presented here should be useful as a reference guide in clinical practice, especially for clinical gene testing and enrollment in gene therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hamel CP, Tsilou E, Harris E, Pfeffer BA, Hooks JJ, Detrick B, Redmond TM. A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina. J Neurosc Res. 1993;34:414–25.

    Article  CAS  Google Scholar 

  2. Moiseyev G, Takahashi Y, Chen Y, Gentleman S, Redmond TM, Crouch RK, Ma JX. RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle. J Biol Chem. 2006;281:2835–40.

    Article  CAS  PubMed  Google Scholar 

  3. Schatz P, Preising M, Lorenz B, Sander B, Larsen M, Rosenberg T. Fundus albipunctatus associated with compound heterozygous mutations in RPE65. Ophthalmology. 2011;118:888–94.

    Article  PubMed  Google Scholar 

  4. Yang G, Liu Z, Xie S, Li C, Lv L, Zhang M, Zhao J. Genetic and phenotypic characteristics of four Chinese families with fundus albipunctatus. Sci Rep. 2017;7:46285.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Li S, Xiao X, Yi Z, Sun W, Wang P, Zhang Q. RPE65 mutation frequency and phenotypic variation according to exome sequencing in a tertiary centre for genetic eye diseases in China. Acta Ophthalmol. 2020;8(2):e181–90.

    Google Scholar 

  6. Bowne SJ, Humphries MM, Sullivan LS, Kenna PF, Tam LC, Kiang AS, Campbell M, Weinstock GM, Koboldt DC, Ding L, et al. A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement. Eur J Hum Genet. 2011;19:1074–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hull S, Mukherjee R, Holder GE, Moore AT, Webster AR. The clinical features of retinal disease due to a dominant mutation in RPE65. Mol Vis. 2016;22:626–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Weleber RG, Francis PJ, Trzupek KM, Beattie C. Leber congenital amaurosis. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews((R)), Seattle (WA); 1993.

    Google Scholar 

  9. Weleber RG, Michaelides M, Trzupek KM, Stover NB, Stone EM. The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2011;52:292–302.

    Article  CAS  PubMed  Google Scholar 

  10. Jacobson SG, Voigt WJ, Parel JM, Apathy PP, Nghiem-Phu L, Myers SW, Patella VM. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 1986;93:1604–11.

    Article  CAS  PubMed  Google Scholar 

  11. Sharif W, Sharif Z. Leber’s congenital amaurosis and the role of gene therapy in congenital retinal disorders. Int J Ophthalmol. 2017;10:480–4.

    PubMed  PubMed Central  Google Scholar 

  12. Pierce EA, Bennett J. The status of RPE65 gene therapy trials: safety and efficacy. Cold Spring Harb Perspect Med. 2015;5:a017285.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Stein L, Roy K, Lei L, Kaushal S. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis. Expert Opin Biol Ther. 2011;11:429–39.

    Article  CAS  PubMed  Google Scholar 

  14. Cideciyan AV. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res. 2010;29:398–427.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Gu SM, Thompson DA, Srikumari CR, Lorenz B, Finckh U, Nicoletti A, Murthy KR, Rathmann M, Kumaramanickavel G, Denton MJ, et al. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet. 1997;17:194–7.

    Article  CAS  PubMed  Google Scholar 

  16. Marlhens F, Bareil C, Griffoin JM, Zrenner E, Amalric P, Eliaou C, Liu SY, Harris E, Redmond TM, Arnaud B, et al. Mutations in RPE65 cause Leber’s congenital amaurosis. Nat Genet. 1997;17:139–41.

    Article  CAS  PubMed  Google Scholar 

  17. Marlhens F, Griffoin JM, Bareil C, Arnaud B, Claustres M, Hamel CP. Autosomal recessive retinal dystrophy associated with two novel mutations in the RPE65 gene. Eur J Hum Genet. 1998;6:527–31.

    Article  CAS  PubMed  Google Scholar 

  18. Morimura H, Fishman GA, Grover SA, Fulton AB, Berson EL, Dryja TP. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc Natl Acad Sci U S A. 1998;95:3088–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Perrault I, Rozet JM, Ghazi I, Leowski C, Bonnemaison M, Gerber S, Ducroq D, Cabot A, Souied E, Dufier JL, et al. Different functional outcome of RetGC1 and RPE65 gene mutations in Leber congenital amaurosis. Am J Hum Genet. 1999;64:1225–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dharmaraj SR, Silva ER, Pina AL, Li YY, Yang JM, Carter CR, Loyer MK, El-Hilali HK, Traboulsi EK, Sundin OK, et al. Mutational analysis and clinical correlation in Leber congenital amaurosis. Ophthalmic Genet. 2000;21:135–50.

    Article  CAS  PubMed  Google Scholar 

  21. Lorenz B, Gyurus P, Preising M, Bremser D, Gu S, Andrassi M, Gerth C, Gal A. Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. Invest Ophthalmol Vis Sci. 2000;41:2735–42.

    CAS  PubMed  Google Scholar 

  22. Lotery AJ, Namperumalsamy P, Jacobson SG, Weleber RG, Fishman GA, Musarella MA, Hoyt CS, Heon E, Levin A, Jan J, et al. Mutation analysis of 3 genes in patients with Leber congenital amaurosis. Arch Ophthalmol. 2000;118:538–43.

    Article  CAS  PubMed  Google Scholar 

  23. Poehner WJ, Fossarello M, Rapoport AL, Aleman TS, Cideciyan AV, Jacobson SG, Wright AF, Danciger M, Farber DB. A homozygous deletion in RPE65 in a small Sardinian family with autosomal recessive retinal dystrophy. Mol Vis. 2000;6:192–8.

    CAS  PubMed  Google Scholar 

  24. Thompson DA, Gyurus P, Fleischer LL, Bingham EL, McHenry CL, Apfelstedt-Sylla E, Zrenner E, Lorenz B, Richards JE, Jacobson SG, et al. Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci. 2000;41:4293–9.

    CAS  PubMed  Google Scholar 

  25. Hamel CP, Griffoin JM, Lasquellec L, Bazalgette C, Arnaud B. Retinal dystrophies caused by mutations in RPE65: assessment of visual functions. Br J Ophthalmol. 2001;85:424–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Simovich MJ, Miller B, Ezzeldin H, Kirkland BT, McLeod G, Fulmer C, Nathans J, Jacobson SG, Pittler SJ. Four novel mutations in the RPE65 gene in patients with Leber congenital amaurosis. Hum Mutat. 2001;18:164.

    Article  CAS  PubMed  Google Scholar 

  27. Felius J, Thompson DA, Khan NW, Bingham EL, Jamison JA, Kemp JA, Sieving PA. Clinical course and visual function in a family with mutations in the RPE65 gene. Arch Ophthalmol. 2002;120:55–61.

    Article  PubMed  Google Scholar 

  28. Joseph B, Srinivasan A, Soumittra N, Vidhya A, Shetty NS, Uthra S, Kumaramanickavel G. RPE65 gene: multiplex PCR and mutation screening in patients from India with retinal degenerative diseases. J Genet. 2002;81:19–23.

    Article  CAS  PubMed  Google Scholar 

  29. Porto FB, Perrault I, Hicks D, Rozet JM, Hanoteau N, Hanein S, Kaplan J, Sahel JA. Prenatal human ocular degeneration occurs in Leber’s congenital amaurosis (LCA2). J Gene Med. 2002;4:390–6.

    Article  PubMed  Google Scholar 

  30. Thompson DA, McHenry CL, Li Y, Richards JE, Othman MI, Schwinger E, Vollrath D, Jacobson SG, Gal A. Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with homoallelism for mutations in RPE65 or MERTK, respectively. Am J Hum Genet. 2002;70:224–9.

    Article  CAS  PubMed  Google Scholar 

  31. Sitorus RS, Lorenz B, Preising MN. Analysis of three genes in Leber congenital amaurosis in Indonesian patients. Vision Res. 2003;43:3087–93.

    Article  CAS  PubMed  Google Scholar 

  32. Yzer S, van den Born LI, Schuil J, Kroes HY, van Genderen MM, Boonstra FN, van den Helm B, Brunner HG, Koenekoop RK, Cremers FP. A Tyr368His RPE65 founder mutation is associated with variable expression and progression of early onset retinal dystrophy in 10 families of a genetically isolated population. J Med Genet. 2003;40:709–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Al-Khayer K, Hagstrom S, Pauer G, Zegarra H, Sears J, Traboulsi EI. Thirty-year follow-up of a patient with leber congenital amaurosis and novel RPE65 mutations. Am J Ophthalmol. 2004;137:375–7.

    Article  PubMed  Google Scholar 

  34. Hanein S, Perrault I, Gerber S, Tanguy G, Barbet F, Ducroq D, Calvas P, Dollfus H, Hamel C, Lopponen T, et al. Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat. 2004;23:306–17.

    Article  CAS  PubMed  Google Scholar 

  35. Kondo H, Qin M, Mizota A, Kondo M, Hayashi H, Hayashi K, Oshima K, Tahira T, Hayashi K. A homozygosity-based search for mutations in patients with autosomal recessive retinitis pigmentosa, using microsatellite markers. Invest Ophthalmol Vis Sci. 2004;45:4433–9.

    Article  PubMed  Google Scholar 

  36. Lorenz B, Wabbels B, Wegscheider E, Hamel CP, Drexler W, Preising MN. Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology. 2004;111:1585–94.

    Article  PubMed  Google Scholar 

  37. Silva E, Dharmaraj S, Li YY, Pina AL, Carter RC, Loyer M, Traboulsi E, Theodossiadis G, Koenekoop R, Sundin O, et al. A missense mutation in GUCY2D acts as a genetic modifier in RPE65-related Leber Congenital Amaurosis. Ophthalmic Genet. 2004;25:205–17.

    Article  CAS  PubMed  Google Scholar 

  38. Booij JC, Florijn RJ, ten Brink JB, Loves W, Meire F, van Schooneveld MJ, de Jong PT, Bergen AA. Identification of mutations in the AIPL1, CRB1, GUCY2D, RPE65, and RPGRIP1 genes in patients with juvenile retinitis pigmentosa. J Med Genet. 2005;42:e67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Galvin JA, Fishman GA, Stone EM, Koenekoop RK. Evaluation of genotype-phenotype associations in leber congenital amaurosis. Retina. 2005;25:919–29.

    Article  PubMed  Google Scholar 

  40. Jacobson SG, Aleman TS, Cideciyan AV, Sumaroka A, Schwartz SB, Windsor EA, Traboulsi EI, Heon E, Pittler SJ, Milam AH, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success. Proc Natl Acad Sci U S A. 2005;102:6177–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Paunescu K, Wabbels B, Preising MN, Lorenz B. Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations. Graefes Arch Clin Exp Ophthalmol. 2005;243:417–26.

    Article  PubMed  Google Scholar 

  42. Zernant J, Kulm M, Dharmaraj S, den Hollander AI, Perrault I, Preising MN, Lorenz B, Kaplan J, Cremers FP, Maumenee I, et al. Genotyping microarray (disease chip) for Leber congenital amaurosis: detection of modifier alleles. Invest Ophthalmol Vis Sci. 2005;46:3052–9.

    Article  PubMed  Google Scholar 

  43. El Matri L, Ambresin A, Schorderet DF, Kawasaki A, Seeliger MW, Wenzel A, Arsenijevic Y, Borruat FX, Munier FL. Phenotype of three consanguineous Tunisian families with early-onset retinal degeneration caused by an R91W homozygous mutation in the RPE65 gene. Graefes Arch Clin Exp Ophthalmol. 2006;244:1104–12.

    Article  PubMed  CAS  Google Scholar 

  44. Wabbels B, Demmler A, Paunescu K, Wegscheider E, Preising MN, Lorenz B. Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2006;244:36–45.

    Article  PubMed  Google Scholar 

  45. Aguirre GK, Komaromy AM, Cideciyan AV, Brainard DH, Aleman TS, Roman AJ, Avants BB, Gee JC, Korczykowski M, Hauswirth WW, et al. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. PLoS Med. 2007;4:e230.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. den Hollander AI, Lopez I, Yzer S, Zonneveld MN, Janssen IM, Strom TM, Hehir-Kwa JY, Veltman JA, Arends ML, Meitinger T, et al. Identification of novel mutations in patients with Leber congenital amaurosis and juvenile RP by genome-wide homozygosity mapping with SNP microarrays. Invest Ophthalmol Vis Sci. 2007;48:5690–8.

    Article  Google Scholar 

  47. Henderson RH, Waseem N, Searle R, van der Spuy J, Russell-Eggitt I, Bhattacharya SS, Thompson DA, Holder GE, Cheetham ME, Webster AR, et al. An assessment of the apex microarray technology in genotyping patients with Leber congenital amaurosis and early-onset severe retinal dystrophy. Invest Ophthalmol Vis Sci. 2007;48:5684–9.

    Article  PubMed  Google Scholar 

  48. Jacobson SG, Aleman TS, Cideciyan AV, Heon E, Golczak M, Beltran WA, Sumaroka A, Schwartz SB, Roman AJ, Windsor EA, et al. Human cone photoreceptor dependence on RPE65 isomerase. Proc Natl Acad Sci U S A. 2007;104:15123–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Jacobson SG, Cideciyan AV, Aleman TS, Sumaroka A, Schwartz SB, Windsor EA, Roman AJ, Heon E, Stone EM, Thompson DA. RDH12 and RPE65, visual cycle genes causing leber congenital amaurosis, differ in disease expression. Invest Ophthalmol Vis Sci. 2007;48:332–8.

    Article  PubMed  Google Scholar 

  50. Simonelli F, Ziviello C, Testa F, Rossi S, Fazzi E, Bianchi PE, Fossarello M, Signorini S, Bertone C, Galantuomo S, et al. Clinical and molecular genetics of Leber’s congenital amaurosis: a multicenter study of Italian patients. Invest Ophthalmol Vis Sci. 2007;48:4284–90.

    Article  PubMed  Google Scholar 

  51. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med. 2008;358:2231–9.

    Article  CAS  PubMed  Google Scholar 

  52. Bereta G, Kiser PD, Golczak M, Sun W, Heon E, Saperstein DA, Palczewski K. Impact of retinal disease-associated RPE65 mutations on retinoid isomerization. Biochemistry. 2008;47:9856–65.

    Article  CAS  PubMed  Google Scholar 

  53. Jacobson SG, Cideciyan AV, Aleman TS, Sumaroka A, Windsor EA, Schwartz SB, Heon E, Stone EM. Photoreceptor layer topography in children with leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2008;49:4573–7.

    Article  PubMed  Google Scholar 

  54. Lorenz B, Poliakov E, Schambeck M, Friedburg C, Preising MN, Redmond TM. A comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutation. Invest Ophthalmol Vis Sci. 2008;49:5235–42.

    Article  PubMed  Google Scholar 

  55. Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med. 2008;358:2240–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Mamatha G, Srilekha S, Meenakshi S, Kumaramanickavel G. Screening of the RPE65 gene in the Asian Indian patients with leber congenital amaurosis. Ophthalmic Genet. 2008;29:73–8.

    Article  CAS  PubMed  Google Scholar 

  57. Seong MW, Kim SY, Yu YS, Hwang JM, Kim JY, Park SS. Molecular characterization of Leber congenital amaurosis in Koreans. Mol Vis. 2008;14:1429–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Jacobson SG, Aleman TS, Cideciyan AV, Roman AJ, Sumaroka A, Windsor EA, Schwartz SB, Heon E, Stone EM. Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2009;50:2368–75.

    Article  PubMed  Google Scholar 

  59. Li Y, Wang H, Peng J, Gibbs RA, Lewis RA, Lupski JR, Mardon G, Chen R. Mutation survey of known LCA genes and loci in the Saudi Arabian population. Invest Ophthalmol Vis Sci. 2009;50:1336–43.

    Article  PubMed  Google Scholar 

  60. Maguire AM, High KA, Auricchio A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli JL, Ying GS, Rossi S, et al. Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: a phase 1 dose-escalation trial. Lancet. 2009; 374:1597–605.

    Google Scholar 

  61. Singh HP, Jalali S, Narayanan R, Kannabiran C. Genetic analysis of Indian families with autosomal recessive retinitis pigmentosa by homozygosity screening. Invest Ophthalmol Vis Sci. 2009;50:4065–71.

    Article  PubMed  Google Scholar 

  62. Sundaresan P, Vijayalakshmi P, Thompson S, Ko AC, Fingert JH, Stone EM. Mutations that are a common cause of Leber congenital amaurosis in northern America are rare in southern India. Mol Vis. 2009;15:1781–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Banin E, Bandah-Rozenfeld D, Obolensky A, Cideciyan AV, Aleman TS, Marks-Ohana D, Sela M, Boye S, Sumaroka A, Roman AJ, et al. Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel. Hum Gene Ther. 2010;21:1749–57.

    Article  CAS  PubMed  Google Scholar 

  64. Coppieters F, Casteels I, Meire F, De Jaegere S, Hooghe S, van Regemorter N, Van Esch H, Matuleviciene A, Nunes L, Meersschaut V, et al. Genetic screening of LCA in Belgium: predominance of CEP290 and identification of potential modifier alleles in AHI1 of CEP290-related phenotypes. Hum Mutat. 2010;31:E1709–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. McKibbin M, Ali M, Mohamed MD, Booth AP, Bishop F, Pal B, Springell K, Raashid Y, Jafri H, Inglehearn CF. Genotype-phenotype correlation for leber congenital amaurosis in Northern Pakistan. Arch Ophthalmol. 2010;128:107–13.

    Article  CAS  PubMed  Google Scholar 

  66. Pasadhika S, Fishman GA, Stone EM, Lindeman M, Zelkha R, Lopez I, Koenekoop RK, Shahidi M. Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2010;51:2608–14.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Bonilha VL, Rayborn ME, Li Y, Grossman GH, Berson EL, Hollyfield JG. Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for retinol isomerase. Invest Ophthalmol Vis Sci. 2011;52:8381–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Li L, Xiao X, Li S, Jia X, Wang P, Guo X, Jiao X, Zhang Q, Hejtmancik JF. Detection of variants in 15 genes in 87 unrelated Chinese patients with Leber congenital amaurosis. PLoS One. 2011;6:e19458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DC, McCague S, Pierce EA, Chen Y, Bennicelli JL, et al. AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med. 2012;4:120ra15.

    Google Scholar 

  70. Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A, et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130:9–24.

    Article  CAS  PubMed  Google Scholar 

  71. Lorenz B, Strohmayr E, Zahn S, Friedburg C, Kramer M, Preising M, Stieger K. Chromatic pupillometry dissects function of the three different light-sensitive retinal cell populations in RPE65 deficiency. Invest Ophthalmol Vis Sci. 2012;53:5641–52.

    Article  CAS  PubMed  Google Scholar 

  72. Xu F, Dong Q, Liu L, Li H, Liang X, Jiang R, Sui R, Dong F. Novel RPE65 mutations associated with Leber congenital amaurosis in Chinese patients. Mol Vis. 2012;18:744–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Chen Y, Zhang Q, Shen T, Xiao X, Li S, Guan L, Zhang J, Zhu Z, Yin Y, Wang P, et al. Comprehensive mutation analysis by whole-exome sequencing in 41 Chinese families with Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2013;54:4351–7.

    Article  CAS  PubMed  Google Scholar 

  74. Kabir F, Naz S, Riazuddin SA, Naeem MA, Khan SN, Husnain T, Akram J, Sieving PA, Hejtmancik JF, Riazuddin S. Novel mutations in RPE65 identified in consanguineous Pakistani families with retinal dystrophy. Mol Vis. 2013;19:1554–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  75. Roman AJ, Cideciyan AV, Schwartz SB, Olivares MB, Heon E, Jacobson SG. Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2013;54:1378–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Testa F, Maguire AM, Rossi S, Pierce EA, Melillo P, Marshall K, Banfi S, Surace EM, Sun J, Acerra C, et al. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2. Ophthalmology. 2013;120:1283–91.

    Article  PubMed  Google Scholar 

  77. Verma A, Perumalsamy V, Shetty S, Kulm M, Sundaresan P. Mutational screening of LCA genes emphasizing RPE65 in South Indian cohort of patients. PLoS One. 2013;8:e73172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Jakobsson C, Othman IS, Munier FL, Schorderet DF. Abouzeid H Cone-rod dystrophy caused by a novel homozygous RPE65 mutation in Leber congenital amaurosis. Klin Monbl Augenheilkd. 2014;231:405–10.

    Article  CAS  PubMed  Google Scholar 

  79. Khan AO, Al-Mesfer S, Al-Turkmani S, Bergmann C, Bolz HJ. Genetic analysis of strictly defined Leber congenital amaurosis with (and without) neurodevelopmental delay. Br J Ophthalmol. 2014;98:1724–8.

    Article  PubMed  Google Scholar 

  80. Koenekoop RK, Sui R, Sallum J, van den Born LI, Ajlan R, Khan A, den Hollander AI, Cremers FP, Mendola JD, Bittner AK, et al. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial. Lancet. 2014;384:1513–20.

    Article  CAS  PubMed  Google Scholar 

  81. Mo G, Ding Q, Chen Z, Li Y, Yan M, Bu L, Song Y, Yin G. A novel mutation in the RPE65 gene causing Leber congenital amaurosis and its transcriptional expression in vitro. PLoS One. 2014;9:e112400.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  82. Ripamonti C, Henning GB, Ali RR, Bainbridge JW, Robbie SJ, Sundaram V, Luong VA, van den Born LI, Casteels I, de Ravel TJ, et al. Nature of the visual loss in observers with Leber’s congenital amaurosis caused by specific mutations in RPE65. Invest Ophthalmol Vis Sci. 2014;55:6817–28.

    Article  CAS  PubMed  Google Scholar 

  83. Maranhao B, Biswas P, Gottsch AD, Navani M, Naeem MA, Suk J, Chu J, Khan SN, Poleman R, Akram J, et al. Investigating the molecular basis of retinal degeneration in a familial cohort of Pakistani decent by exome sequencing. PLoS One. 2015;10:e0136561.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Srilekha S, Arokiasamy T, Srikrupa NN, Umashankar V, Meenakshi S, Sen P, Kapur S, Soumittra N. Homozygosity mapping in Leber congenital amaurosis and autosomal recessive retinitis pigmentosa in South Indian families. PLoS One. 2015;10:e0131679.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  85. Tucker BA, Cranston CM, Anfinson KA, Shrestha S, Streb LM, Leon A, Mullins RF, Stone EM. Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial. Transl Res. 2015;166:740–9. e1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Astuti GD, Bertelsen M, Preising MN, Ajmal M, Lorenz B, Faradz SM, Qamar R, Collin RW, Rosenberg T, Cremers FP. Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark. Eur J Hum Genet. 2016;24:1071–9.

    Article  CAS  PubMed  Google Scholar 

  87. Habibi I, Chebil A, Falfoul Y, Allaman-Pillet N, Kort F, Schorderet DF, El Matri L. Identifying mutations in Tunisian families with retinal dystrophy. Sci Rep. 2016;6:37455.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Hull S, Holder GE, Robson AG, Mukherjee R, Michaelides M, Webster AR, Moore AT. Preserved visual function in retinal dystrophy due to hypomorphic RPE65 mutations. Br J Ophthalmol. 2016;100:1499–505.

    Article  PubMed  Google Scholar 

  89. Katagiri S, Hayashi T, Kondo M, Tsukitome H, Yoshitake K, Akahori M, Ikeo K, Tsuneoka H, Iwata T. RPE65 mutations in two Japanese families with Leber congenital amaurosis. Ophthalmic Genet. 2016;37:161–9.

    Article  CAS  PubMed  Google Scholar 

  90. Biswas P, Duncan JL, Maranhao B, Kozak I, Branham K, Gabriel L, Lin JH, Barteselli G, Navani M, Suk J, et al. Genetic analysis of 10 pedigrees with inherited retinal degeneration by exome sequencing and phenotype-genotype association. Physiol Genomics. 2017;49:216–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Liu J, Bu J A Gene scan study of RPE65 in Chinese patients with Leber congenital amaurosis. Chin Med J (Engl). 2017;130:2709–12.

    Google Scholar 

  92. Katagiri S, Hosono K, Hayashi T, Kurata K, Mizobuchi K, Matsuura T, Yoshitake K, Iwata T, Nakano T, Hotta Y. Early onset flecked retinal dystrophy associated with new compound heterozygous RPE65 variants. Mol Vis. 2018;24:286–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  93. Kumaran N, Ripamonti C, Kalitzeos A, Rubin GS, Bainbridge JWB, Michaelides M. Severe loss of Tritan color discrimination in RPE65 associated Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2018;59:85–93.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Villanueva A, Biswas P, Kishaba K, Suk J, Tadimeti K, Raghavendra PB, Nadeau K, Lamontagne B, Busque L, Geoffroy S, et al. Identification of the genetic determinants responsible for retinal degeneration in families of Mexican descent. Ophthalmic Genet. 2018;39:73–9.

    Article  CAS  PubMed  Google Scholar 

  95. Yzer S, Leroy BP, De Baere EF, de Ravel TJ, Zonneveld MN, Voesenek K, Kellner U, Ciriano JPM, de Faber JTHN, Rohrschneider K, et al. Microarray-based mutation detection and phenotypic characterization of patients with Leber congenital amaurosis. Invest Ophth Vis Sci. 2006;47:1167–76.

    Article  Google Scholar 

  96. Xu Y, Xiao XS, Li SQ, Jia XY, Xin W, Wang PF, Sun WM, Huang L, Guo XM, Zhang QJ. Molecular genetics of Leber congenital amaurosis in Chinese: New data from 66 probands and mutation overview of 159 probands. Exp Eye Res. 2016;149:93–9.

    Article  CAS  PubMed  Google Scholar 

  97. Avila-Fernandez A, Cantalapiedra D, Aller E, Vallespin E, Aguirre-Lamban J, Blanco-Kelly F, Corton M, Riveiro-Alvarez R, Allikmets R, Trujillo-Tiebas MJ, et al. Mutation analysis of 272 Spanish families affected by autosomal recessive retinitis pigmentosa using a genotyping microarray. Mol Vis. 2010;16:2550–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Neveling K, Collin RW, Gilissen C, van Huet RA, Visser L, Kwint MP, Gijsen SJ, Zonneveld MN, Wieskamp N, de Ligt J, et al. Next-generation genetic testing for retinitis pigmentosa. Hum Mutat. 2012;33:963–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Abu-Safieh L, Alrashed M, Anazi S, Alkuraya H, Khan AO, Al-Owain M, Al-Zahrani J, Al-Abdi L, Hashem M, Al-Tarimi S, et al. Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes. Genome Res. 2013;23:236–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Eisenberger T, Neuhaus C, Khan AO, Decker C, Preising MN, Friedburg C, Bieg A, Gliem M, Charbel Issa P, Holz FG, et al. Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One. 2013;8:e78496.

    Google Scholar 

  101. Fu Q, Wang F, Wang H, Xu F, Zaneveld JE, Ren H, Keser V, Lopez I, Tuan HF, Salvo JS, et al. Next-generation sequencing-based molecular diagnosis of a Chinese patient cohort with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013;54:4158–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, Makiyama Y, Morooka S, Matsuda F, Yoshimura N. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci. 2014;55:7369–75.

    Article  CAS  PubMed  Google Scholar 

  103. Wang J, Zhang VW, Feng Y, Tian X, Li FY, Truong C, Wang G, Chiang PW, Lewis RA, Wong LJ. Dependable and efficient clinical utility of target capture-based deep sequencing in molecular diagnosis of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014;55:6213–23.

    Article  CAS  PubMed  Google Scholar 

  104. Beryozkin A, Shevah E, Kimchi A, Mizrahi-Meissonnier L, Khateb S, Ratnapriya R, Lazar CH, Blumenfeld A, Ben-Yosef T, Hemo Y, et al. Whole exome sequencing reveals mutations in known retinal disease genes in 33 out of 68 Israeli families with inherited retinopathies. Sci Rep. 2015;5:13187.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Ge Z, Bowles K, Goetz K, Scholl HP, Wang F, Wang X, Xu S, Wang K, Wang H, Chen R. NGS-based molecular diagnosis of 105 eyeGENE((R)) probands with retinitis pigmentosa. Sci Rep. 2015;5:18287.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Huang XF, Huang F, Wu KC, Wu J, Chen J, Pang CP, Lu F, Qu J, Jin ZB. Genotype-phenotype correlation and mutation spectrum in a large cohort of patients with inherited retinal dystrophy revealed by next-generation sequencing. Genet Med. 2015;17:271–8.

    Article  CAS  PubMed  Google Scholar 

  107. Wang H, Wang X, Zou X, Xu S, Li H, Soens ZT, Wang K, Li Y, Dong F, Chen R, et al. Comprehensive molecular diagnosis of a large Chinese Leber congenital amaurosis cohort. Invest Ophthalmol Vis Sci. 2015;56:3642–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Ellingford JM, Barton S, Bhaskar S, O’Sullivan J, Williams SG, Lamb JA, Panda B, Sergouniotis PI, Gillespie RL, Daiger SP, et al. Molecular findings from 537 individuals with inherited retinal disease. J Med Genet. 2016;53:761–7.

    Article  CAS  PubMed  Google Scholar 

  109. Patel N, Aldahmesh MA, Alkuraya H, Anazi S, Alsharif H, Khan AO, Sunker A, Al-Mohsen S, Abboud EB, Nowilaty SR, et al. Expanding the clinical, allelic, and locus heterogeneity of retinal dystrophies. Genet Med. 2016;18:554–62.

    Article  CAS  PubMed  Google Scholar 

  110. Wang S, Zhang Q, Zhang X, Wang Z, Zhao P. Clinical and genetic characteristics of Leber congenital amaurosis with novel mutations in known genes based on a Chinese eastern coast Han population. Graefes Arch Clin Exp Ophthalmol. 2016;254:2227–38.

    Article  CAS  PubMed  Google Scholar 

  111. Li L, Chen Y, Jiao X, Jin C, Jiang D, Tanwar M, Ma Z, Huang L, Ma X, Sun W, et al. Homozygosity mapping and genetic analysis of autosomal recessive retinal dystrophies in 144 consanguineous Pakistani families. Invest Ophthalmol Vis Sci. 2017;58:2218–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Porto FBO, Jones EM, Branch J, Soens ZT, Maia IM, Sena IFG, Sampaio SAM, Simoes RT, Chen R Molecular screening of 43 Brazilian families diagnosed with Leber congenital amaurosis or early-onset severe retinal dystrophy. Genes (Basel). 2017; 8.

    Google Scholar 

  113. Riera M, Navarro R, Ruiz-Nogales S, Mendez P, Bures-Jelstrup A, Corcostegui B, Pomares E. Whole exome sequencing using Ion Proton system enables reliable genetic diagnosis of inherited retinal dystrophies. Sci Rep. 2017;7:42078.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Soens ZT, Branch J, Wu S, Yuan Z, Li Y, Li H, Wang K, Xu M, Rajan L, Motta FL, et al. Leveraging splice-affecting variant predictors and a minigene validation system to identify Mendelian disease-causing variants among exon-captured variants of uncertain significance. Hum Mutat. 2017;38:1521–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Thompson JA, De Roach JN, McLaren TL, Montgomery HE, Hoffmann LH, Campbell IR, Chen FK, Mackey DA, Lamey TM. The genetic profile of Leber congenital amaurosis in an Australian cohort. Mol Genet Genomic Med. 2017;5:652–67.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Huang H, Chen Y, Chen H, Ma Y, Chiang PW, Zhong J, Liu X, Asan, Wu J, Su Y, et al. Systematic evaluation of a targeted gene capture sequencing panel for molecular diagnosis of retinitis pigmentosa. PLoS One. 2018;13:e0185237.

    Google Scholar 

  117. Srikrupa NN, Srilekha S, Sen P, Arokiasamy T, Meenakshi S, Bhende M, Kapur S, Soumittra N. Genetic profile and mutation spectrum of Leber congenital amaurosis in a larger Indian cohort using high throughput targeted re-sequencing. Clin Genet. 2018;93:329–39.

    Article  CAS  PubMed  Google Scholar 

  118. Chung DC, Bertelsen M, Lorenz B, Pennesi ME, Leroy BP, Hamel CP, Pierce E, Sallum J, Larsen M, Stieger K, et al. The natural history of inherited retinal dystrophy due to biallelic mutations in the RPE65 gene. Am J Ophthalmol. 2019;199:58–70.

    Article  CAS  PubMed  Google Scholar 

  119. Wang L, Zhang J, Chen N, Wang L, Zhang F, Ma Z, Li G, Yang L Application of whole exome and targeted panel sequencing in the clinical molecular diagnosis of 319 Chinese families with inherited retinal dystrophy and comparison study. Genes (Basel). 2018;9.

    Google Scholar 

  120. Xiao X, Mai G, Li S, Guo X, Zhang Q. Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy. Biochem Biophys Res Commun. 2011;409:181–6.

    Article  CAS  PubMed  Google Scholar 

  121. Redmond TM. Focus on molecules: RPE65, the visual cycle retinol isomerase. Exp Eye Res. 2009;88:846–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the Science and Technology Planning Projects of Guangdong (2015A030401032), National Natural Science Foundation of China (81371058), the Key Projects of Guangzhou (201607020013), and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qingjiong Zhang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yi, Z., Zeitz, C., Iwata, T., Hejtmancik, J.F., Zhang, Q. (2021). Genotype–Phenotype of RPE65 Mutations: A Reference Guide for Gene Testing and Its Clinical Application. In: Prakash, G., Iwata, T. (eds) Advances in Vision Research, Volume III. Essentials in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-15-9184-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-9184-6_14

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-9183-9

  • Online ISBN: 978-981-15-9184-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics